National Centre for
Pharmacoeconomics

NCPE Ireland

Osilodrostat (Isturisa®). HTA ID: 22023 - May 17, 2022
Ciltacabtagene autoleucel (Carvykti®). HTA ID: 22021 - May 12, 2022
Cabozantinib (Cabometyx®) in combination with nivolumab (Opdivo®) for 1L RCC. HTA ID: 22018 - May 11, 2022
Ivacaftor/tezacaftor/elexacaftor (Kaftrio®) HTA ID: 22022. - May 10, 2022
Abemaciclib (Verzenios®) for adjuvant HR positive, HER2 negative, node positive early breast cancer. HTA ID: 22020 - May 6, 2022
Pomalidomide (Imnovid®) in combination with bortezomib and dexamethasone. HTA ID: 22016 - May 5, 2022
Defatted powder of Arachis hypogaea L., semen (peanuts) (Palforzia®). HTA ID: 22019 - May 5, 2022
Empagliflozin (Jardiance®). HTA ID: 21030 - April 28, 2022
Tixagevimab /cilgavimab (Evusheld®). HTA ID: 22015 - April 11, 2022
Solriamfetol (Sunosi®). HTA ID: 22017 - April 11, 2022